230 related articles for article (PubMed ID: 21074540)
1. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.
Adluri RS; Thirunavukkarasu M; Zhan L; Akita Y; Samuel SM; Otani H; Ho YS; Maulik G; Maulik N
J Mol Cell Cardiol; 2011 Jan; 50(1):239-47. PubMed ID: 21074540
[TBL] [Abstract][Full Text] [Related]
2. Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.
Adluri RS; Thirunavukkarasu M; Zhan L; Dunna NR; Akita Y; Selvaraju V; Otani H; Sanchez JA; Ho YS; Maulik N
PLoS One; 2012; 7(3):e34790. PubMed ID: 22523530
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.
Samuel SM; Thirunavukkarasu M; Penumathsa SV; Koneru S; Zhan L; Maulik G; Sudhakaran PR; Maulik N
Circulation; 2010 Mar; 121(10):1244-55. PubMed ID: 20194885
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
6. Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1.
D Annunzio V; Perez V; Mazo T; Muñoz MC; Dominici FP; Carreras MC; Poderoso JJ; Sadoshima J; Gelpi RJ
Oncotarget; 2016 Mar; 7(11):11889-98. PubMed ID: 26933812
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation.
Chen B; Nelin VE; Locy ML; Jin Y; Tipple TE
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L389-95. PubMed ID: 23812635
[TBL] [Abstract][Full Text] [Related]
8. Txnip C247S mutation protects the heart against acute myocardial infarction.
Nakayama Y; Mukai N; Wang BF; Yang K; Patwari P; Kitsis RN; Yoshioka J
J Mol Cell Cardiol; 2021 Jun; 155():36-49. PubMed ID: 33652022
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1.
Turoczi T; Chang VW; Engelman RM; Maulik N; Ho YS; Das DK
J Mol Cell Cardiol; 2003 Jun; 35(6):695-704. PubMed ID: 12788387
[TBL] [Abstract][Full Text] [Related]
10. CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice.
Xu CW; Zhang TP; Wang HX; Yang H; Li HH
Cell Physiol Biochem; 2013; 31(2-3):199-208. PubMed ID: 23485987
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.
Hoehn M; Zhang Y; Xu J; Gergs U; Boknik P; Werdan K; Neumann J; Ebelt H
Int J Cardiol; 2015 Mar; 183():39-46. PubMed ID: 25662052
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endogenous thioredoxin-1 in the heart of transgenic mice does not confer cardioprotection in ischemic postconditioning.
Perez V; D Annunzio V; Mazo T; Marchini T; Caceres L; Evelson P; Gelpi RJ
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):315-322. PubMed ID: 27682518
[TBL] [Abstract][Full Text] [Related]
13. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
14. HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.
Li J; Zhang Y; Li C; Xie J; Liu Y; Zhu W; Zhang X; Jiang S; Liu L; Ding Z
Cardiovasc Res; 2013 Sep; 99(4):674-84. PubMed ID: 23729663
[TBL] [Abstract][Full Text] [Related]
15. Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.
Selvaraju V; Suresh SC; Thirunavukkarasu M; Mannu J; Foye JLC; Mathur PP; Palesty JA; Sanchez JA; McFadden DW; Maulik N
J Cardiovasc Transl Res; 2017 Apr; 10(2):209-220. PubMed ID: 28281242
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
17. Danlou Tablet Protects Against Myocardial Infarction Through Promoting eNOS-Dependent Endothelial Protection and Angiogenesis.
Zhu Y; Chai Y; Su Z; Qi W; Yin M; Li L; Wei M; Ge J; Wang H; Jiao Z; Bei Y
J Cardiovasc Transl Res; 2024 Apr; 17(2):403-416. PubMed ID: 37784003
[TBL] [Abstract][Full Text] [Related]
18. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
Smith RS; Agata J; Xia CF; Chao L; Chao J
Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice.
Sánchez-Villamil JP; D'Annunzio V; Finocchietto P; Holod S; Rebagliati I; Pérez H; Peralta JG; Gelpi RJ; Poderoso JJ; Carreras MC
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):323-334. PubMed ID: 27592449
[TBL] [Abstract][Full Text] [Related]
20. TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis.
Wang J; Wang XJ; Zhang Y; Shi WJ; Lei ZD; Jiao XY
Cardiovasc Diagn Ther; 2022 Jun; 12(3):289-304. PubMed ID: 35800356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
